Literature DB >> 26361411

On pancreatic cancer screening by magnetic resonance imaging with the recent evidence by Del Chiaro and colleagues.

Yì-Xiáng J Wáng1, Jing-Shan Gong1, Romaric Loffroy1.   

Abstract

Entities:  

Year:  2015        PMID： 26361411      PMCID： PMC4560739          DOI： 10.3978/j.issn.1000-9604.2015.06.09

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  37 in total

Review 1.  Cystic lesions and intraductal neoplasms of the pancreas.

Authors:  Kenneth E Fasanella; Kevin McGrath
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

2.  The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.

Authors:  Umashankar K Ballehaninna; Ronald S Chamberlain
Journal:  J Gastrointest Oncol       Date:  2012-06

3.  Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.

Authors:  Jiang Long; Guo-pei Luo; Zhi-wen Xiao; Zu-qiang Liu; Meng Guo; Liang Liu; Chen Liu; Jin Xu; Yu-tang Gao; Ying Zheng; Chunxiao Wu; Quan-xing Ni; Min Li; Xianjun Yu
Journal:  Cancer Lett       Date:  2014-01-21       Impact factor: 8.679

4.  Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.

Authors:  Marco Del Chiaro; Caroline S Verbeke; Nikolaos Kartalis; Raffaella Pozzi Mucelli; Peter Gustafsson; Johan Hansson; Stephan L Haas; Ralf Segersvärd; Åke Andren-Sandberg; J-Matthias Löhr
Journal:  JAMA Surg       Date:  2015-06       Impact factor: 14.766

5.  Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality?

Authors:  Victoria Chernyak; Milana Flusberg; Linda B Haramati; Alla M Rozenblit; Eran Bellin
Journal:  Radiology       Date:  2014-08-12       Impact factor: 11.105

6.  Pancreatic FNA in 1000 cases: a comparison of imaging modalities.

Authors:  Keith E Volmar; Robin T Vollmer; Paul S Jowell; Rendon C Nelson; H Bill Xie
Journal:  Gastrointest Endosc       Date:  2005-06       Impact factor: 9.427

7.  Cost-effectiveness of whole-body CT screening.

Authors:  Molly T Beinfeld; Eve Wittenberg; G Scott Gazelle
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

8.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

Review 9.  Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.

Authors:  M J Duffy; C Sturgeon; R Lamerz; C Haglund; V L Holubec; R Klapdor; A Nicolini; O Topolcan; V Heinemann
Journal:  Ann Oncol       Date:  2009-08-18       Impact factor: 32.976

Review 10.  Imaging diagnosis of pancreatic cancer: a state-of-the-art review.

Authors:  Eun Sun Lee; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742
View more
  1 in total

Review 1.  T1ρ magnetic resonance: basic physics principles and applications in knee and intervertebral disc imaging.

Authors:  Yì-Xiáng J Wáng; Qinwei Zhang; Xiaojuan Li; Weitian Chen; Anil Ahuja; Jing Yuan
Journal:  Quant Imaging Med Surg       Date:  2015-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.